Division of Genetics, Department of Medicine, Brigham and Women's Hospital, 41 Avenue Louis Pasteur, Suite 301, Boston, MA, 02115, USA.
Section of Preventive Medicine and Epidemiology, Department of Medicine, Boston University School of Medicine, 801 Massachusetts Avenue, Suite 470, Boston, MA, 02118, USA.
Genome Med. 2019 Feb 27;11(1):10. doi: 10.1186/s13073-019-0619-9.
Increasing numbers of healthy individuals are undergoing predispositional personal genome sequencing. Here we describe the design and early outcomes of the PeopleSeq Consortium, a multi-cohort collaboration of predispositional genome sequencing projects, which is examining the medical, behavioral, and economic outcomes of returning genomic sequencing information to healthy individuals.
Apparently healthy adults who participated in four of the sequencing projects in the Consortium were included. Web-based surveys were administered before and after genomic results disclosure, or in some cases only after results disclosure. Surveys inquired about sociodemographic characteristics, motivations and concerns, behavioral and medical responses to sequencing results, and perceived utility.
Among 1395 eligible individuals, 658 enrolled in the Consortium when contacted and 543 have completed a survey after receiving their genomic results thus far (mean age 53.0 years, 61.4% male, 91.7% white, 95.5% college graduates). Most participants (98.1%) were motivated to undergo sequencing because of curiosity about their genetic make-up. The most commonly reported concerns prior to pursuing sequencing included how well the results would predict future risk (59.2%) and the complexity of genetic variant interpretation (56.8%), while 47.8% of participants were concerned about the privacy of their genetic information. Half of participants reported discussing their genomic results with a healthcare provider during a median of 8.0 months after receiving the results; 13.5% reported making an additional appointment with a healthcare provider specifically because of their results. Few participants (< 10%) reported making changes to their diet, exercise habits, or insurance coverage because of their results. Many participants (39.5%) reported learning something new to improve their health that they did not know before. Reporting regret or harm from the decision to undergo sequencing was rare (< 3.0%).
Healthy individuals who underwent predispositional sequencing expressed some concern around privacy prior to pursuing sequencing, but were enthusiastic about their experience and not distressed by their results. While reporting value in their health-related results, few participants reported making medical or lifestyle changes.
越来越多的健康个体正在接受倾向性个人基因组测序。在这里,我们描述了 PeopleSeq 联盟的设计和早期结果,该联盟是一个由倾向性基因组测序项目组成的多队列合作组织,正在研究向健康个体返还基因组测序信息的医疗、行为和经济结果。
本研究纳入了联盟中四个测序项目的参与者。在基因组结果披露之前或之后(在某些情况下仅在结果披露之后)进行基于网络的调查。调查询问了社会人口统计学特征、动机和关注点、对测序结果的行为和医学反应以及感知效用。
在 1395 名符合条件的个体中,有 658 名在联系时加入了联盟,并且到目前为止已有 543 名完成了调查(平均年龄 53.0 岁,61.4%为男性,91.7%为白人,95.5%为大学毕业生)。大多数参与者(98.1%)出于对自己遗传构成的好奇而选择进行测序。在进行测序之前,最常报告的关注点包括结果对未来风险的预测程度(59.2%)和遗传变异解释的复杂性(56.8%),而 47.8%的参与者担心他们的遗传信息的隐私。有一半的参与者报告在收到结果后的中位数 8.0 个月内与医疗保健提供者讨论了他们的基因组结果;13.5%的参与者报告因结果专门与医疗保健提供者预约。由于结果,很少有参与者(<10%)报告改变他们的饮食、运动习惯或保险覆盖范围。许多参与者(39.5%)报告学到了一些以前不知道的改善健康的新方法。报告因决定进行测序而感到后悔或受到伤害的情况很少(<3.0%)。
接受倾向性测序的健康个体在进行测序之前对隐私问题表示了一些担忧,但对他们的体验感到热情,并且不受结果的困扰。虽然报告了与健康相关的结果有价值,但很少有参与者报告进行医疗或生活方式的改变。